<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: inhaler</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>FDA approves once-a-day inhaler from Glaxo</title>
   	 <description>The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.</description>
     <link>http://medicalxpress.com/news/2013-05-fda-once-a-day-inhaler-glaxo.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 10 May 2013 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news287408576</guid>
	 
</item>
<item>
     <title>US panel backs inhaler drug for lung disease</title>
   	 <description>A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.</description>
     <link>http://medicalxpress.com/news/2013-04-panel-inhaler-drug-lung-disease.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 17 Apr 2013 17:00:11 EST</pubDate>
	 <guid isPermaLink="false">news285435945</guid>
	 
</item>
<item>
     <title>Italy bans minors from buying electronic cigarettes</title>
   	 <description>Italy on Tuesday announced plans to raise the legal limit for buying electronic cigarettes to 18 years from a previous 16, citing the high dose of nicotine inhaled when using the smokeless product.</description>
     <link>http://medicalxpress.com/news/2013-04-italy-minors-electronic-cigarettes.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 02 Apr 2013 13:51:50 EST</pubDate>
	 <guid isPermaLink="false">news284129502</guid>
	 
</item>
<item>
     <title>Inhaler approved for cystic fibrosis patients</title>
   	 <description>(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage the lungs.</description>
     <link>http://medicalxpress.com/news/2013-03-inhaler-cystic-fibrosis-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 25 Mar 2013 17:50:01 EST</pubDate>
	 <guid isPermaLink="false">news283451913</guid>
	 
</item>
<item>
     <title>Single combo inhaler beats standard rx in asthma</title>
   	 <description>(HealthDay)—Maintenance and reliever therapy with a single inhaled corticosteroid plus a rapid-onset, long-acting, β2 agonist (formoterol) seems beneficial for patients with asthma, according to two studies published in the March issue of The Lancet Respiratory Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-combo-inhaler-standard-rx-asthma.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 05 Mar 2013 17:34:25 EST</pubDate>
	 <guid isPermaLink="false">news281727258</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/singlecomboi.jpg" width="90" height="90" />
</item>
<item>
     <title>Cost of medication and stigma leading asthma sufferers to risk health</title>
   	 <description>The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.</description>
     <link>http://medicalxpress.com/news/2013-02-medication-stigma-asthma-health.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 20 Feb 2013 09:23:41 EST</pubDate>
	 <guid isPermaLink="false">news280574610</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/costofmedica.jpg" width="90" height="90" />
</item>
<item>
     <title>Added benefit of aclidinium bromide is not proven</title>
   	 <description>The drug aclidinium bromide (trade names Eklira, Bretaris) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the &quot;Act on the Reform of the Market for Medicinal Products&quot; (AMNOG). No proof of an added benefit of aclidinium bromide compared with the appropriate comparator therapy (ACT) can be inferred from the data in the drug manufacturer's dossier.</description>
     <link>http://medicalxpress.com/news/2013-01-added-benefit-aclidinium-bromide-proven.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 30 Jan 2013 09:38:03 EST</pubDate>
	 <guid isPermaLink="false">news278760982</guid>
	 
</item>
<item>
     <title>FDA panel backs long-acting Boehringer inhaler</title>
   	 <description>(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.</description>
     <link>http://medicalxpress.com/news/2013-01-fda-panel-long-acting-boehringer-inhaler.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 29 Jan 2013 16:00:46 EST</pubDate>
	 <guid isPermaLink="false">news278697626</guid>
	 
</item>
<item>
     <title>Why are kids in asthma hotspots in NYC more likely to visit the ER? Exercise may be a factor</title>
   	 <description>Asthmatic children in New York City neighborhoods with high rates of asthma make many more visits to the emergency room (ER) than those who live in other parts of the city. While socioeconomic factors such as lack of adequate preventive care are part of the equation (high-asthma neighborhoods tend to be lower income), new research points to a possible biological basis for the disparity. Asthmatic children living in asthma hotspots were twice as likely to experience a common symptom known as exercise-induced wheeze than were those in neighborhoods with lower asthma rates.</description>
     <link>http://medicalxpress.com/news/2012-12-kids-asthma-hotspots-nyc-er.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Mon, 17 Dec 2012 00:20:01 EST</pubDate>
	 <guid isPermaLink="false">news274903068</guid>
	 
</item>
<item>
     <title>1990s trial gave early danger signs for asthma drugs</title>
   	 <description>The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.</description>
     <link>http://medicalxpress.com/news/2012-11-1990s-trial-gave-early-danger.html</link>
	 <category>Medications</category>
	 <pubDate>Sun, 25 Nov 2012 19:00:02 EST</pubDate>
	 <guid isPermaLink="false">news273086605</guid>
	 
</item>
<item>
     <title>Healthcare professionals as bad as patients at good respiratory inhaler technique</title>
   	 <description>Healthcare professionals are as bad as patients when it comes to knowing how to use inhalers prescribed for asthma and other respiratory conditions correctly, says an editorial in Drug and Therapeutics Bulletin (DTB).</description>
     <link>http://medicalxpress.com/news/2012-10-healthcare-professionals-bad-patients-good.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 03 Oct 2012 18:30:03 EST</pubDate>
	 <guid isPermaLink="false">news268504686</guid>
	 
</item>
<item>
     <title>Breathable treatment to help prevent asthma attacks</title>
   	 <description>Details of a treatment that could help asthmatics fight infections that trigger 80% of asthma attacks, developed by University of Southampton spin-out company Synairgen, will be presented to European respiratory experts on Sunday 2 September.</description>
     <link>http://medicalxpress.com/news/2012-08-breathable-treatment-asthma.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 31 Aug 2012 11:07:05 EST</pubDate>
	 <guid isPermaLink="false">news265630016</guid>
	 
</item>
<item>
     <title>Tudorza pressair approved for COPD</title>
   	 <description>(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older.</description>
     <link>http://medicalxpress.com/news/2012-07-tudorza-pressair-copd.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 24 Jul 2012 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news262354575</guid>
	 
</item>
<item>
     <title>Scientists discover new type of cell with a key role in treatment-resistant asthma</title>
   	 <description>For most people with asthma, a couple of puffs from an inhaler filled with steroids makes breathing easy. But if their lungs become resistant to the calming effect of that medicine, they live in fear of severe asthma attacks that could send them to the hospital &amp;#150; or worse.</description>
     <link>http://medicalxpress.com/news/2012-05-scientists-cell-key-role-treatment-resistant.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Mon, 07 May 2012 13:19:21 EST</pubDate>
	 <guid isPermaLink="false">news255615553</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/18-scientistsdi.jpg" width="90" height="90" />
</item>
<item>
     <title>Largest gene therapy trial for cystic fibrosis begins</title>
   	 <description>(Medical Xpress) -- British scientists are to carry out the largest trial anywhere in the world of a gene therapy for cystic fibrosis.</description>
     <link>http://medicalxpress.com/news/2012-03-largest-gene-therapy-trial-cystic.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 16 Mar 2012 08:35:02 EST</pubDate>
	 <guid isPermaLink="false">news251105692</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/largestgenet.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA phases out inhaler due to environmental impact</title>
   	 <description>(AP) --  Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government's latest attempt to protect the Earth's atmosphere.</description>
     <link>http://medicalxpress.com/news/2011-09-fda-phases-inhaler-due-environmental.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 22 Sep 2011 12:35:22 EST</pubDate>
	 <guid isPermaLink="false">news235913625</guid>
	 
</item>
<item>
     <title>A closer look at the placebo effect</title>
   	 <description>Placebos are &quot;dummy pills&quot; often used in research trials to test new drug therapies and the &quot;placebo effect&quot; is the benefit patients receive from a treatment that has no active ingredients. Many claim that the placebo effect is a critical component of clinical practice.</description>
     <link>http://medicalxpress.com/news/2011-07-closer-placebo-effect.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 13 Jul 2011 17:27:11 EST</pubDate>
	 <guid isPermaLink="false">news229796801</guid>
	 
</item>
<item>
     <title>Researchers question safety of mist inhalers for delivering common drug for chronic lung disease</title>
   	 <description>People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.</description>
     <link>http://medicalxpress.com/news/2011-06-safety-mist-inhalers-common-drug.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 15 Jun 2011 04:13:05 EST</pubDate>
	 <guid isPermaLink="false">news227329923</guid>
	 
</item>
<item>
     <title>Fake cigarettes increase success rate for quitting smoking</title>
   	 <description>Nicotine-free plastic inhalers may increase a smoker's chance of quitting, according to new research published online in the European Respiratory Journal.</description>
     <link>http://medicalxpress.com/news/2011-05-fake-cigarettes-success.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 12 May 2011 03:34:33 EST</pubDate>
	 <guid isPermaLink="false">news224390062</guid>
	 
</item>
<item>
     <title>Nitric oxide impacts source of sickle cell pain crisis</title>
   	 <description>Nitric oxide gas appears to directly impact the source of the classic, disabling pain crises of sickle cell disease, Georgia Health Sciences University researchers report.</description>
     <link>http://medicalxpress.com/news/2011-05-nitric-oxide-impacts-source-sickle.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 09 May 2011 15:55:01 EST</pubDate>
	 <guid isPermaLink="false">news224175262</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/nitricoxidei.jpg" width="90" height="84" />
</item>


</channel>
</rss>
